Gapping up
In reaction to strong earnings/guidance:
- GBX +3.2%
Other news:
- BOOT +7.2% (to join S&P SmallCap 600)
- CCS +7% (ticking higher; to join S&P SmallCap 600)
- ZYNE +3.6% (continued momentum)
- ACB +3.2% (selected by the German Federal Institute for Drugs and Medical Devices as one of three winners in the public tender to cultivate and distribute medical cannabis in Germany)
Analyst comments:
- CRBP +4.5% (initiated with a Buy at Jefferies)
- BBBY +3.5% (upgraded to Equal-Weight from Underweight at Morgan Stanley)
- FOLD +1.4% (initiated with a Buy at Janney)
- LPX +1.3% (upgraded to Overweight from Equal-Weight at Stephens)
- WY +1.3% (upgraded to Overweight from Equal-Weight at Stephens)
- CFX +0.9% (resumed with a Buy from a Neutral at Goldman)